Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL

Journal of Experimental Medicine

Volumn 202, Issue 8, 2005, Pages 1109-1119

  Hegde, Nagendra R ^c   Dunn, Claire ^a   Lewinsohn, David M ^b   Jarvis, Michael A ^a   Nelson, Jay A ^a   Johnson, David C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD4 ANTIGEN; GLYCOPROTEIN B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS PROTEIN; CELL PROTEIN; MEMBRANE PROTEIN; PROTEINASE; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CELL COMPARTMENTALIZATION; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; ENDOTHELIUM CELL; EPITHELIUM CELL; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ASSEMBLY; ACIDITY; CELL SELECTION; CELL STIMULATION; HOST CELL; MOLECULAR CLONING; NONHUMAN; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; ENDOCYTOSIS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE SUBSETS; MICROSCOPY, FLUORESCENCE; NEUROGLIA; T-LYMPHOCYTES, CYTOTOXIC; VIRAL ENVELOPE PROTEINS;

ADENOVIRIDAE; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 27544484202     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20050162     Document Type: Article

References (68)

1. Rudensky, A., P. Preston-Hurlburt, S.C. Hong, A. Barlow, and C.A. Janeway Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature. 353:622-627.
2. Chicz, R.M., R.G. Urban, J.C. Gorga, D.A. Vignali, W.S. Lane, and J.L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27-47.
3. Lich, J.D., J.F. Elliott, and J.S. Blum. 2000. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J. Exp. Med. 191:1513-1524.
4. Nimmerjahn, F., S. Milosevic, U. Behrends, E.M. Jaffee, D.M. Pardoll, G.W. Bornkamm, and J. Mautner. 2003. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 33:1250-1259.
5. Dani, A., A. Chaudhry, P. Mukherjee, D. Rajagopal, S. Bhatia, A. George, V. Bal, S. Rath, and S. Mayor. 2004. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J. Cell Sci. 117:4219-4230.
6. Paludan, C., D. Schmid, M. Landthaler, M. Vockerodt, D. Kube, T. Tuschl, and C. Munz. 2004. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science. 307:593-596.
7. Tewari, M.K., G. Sinnathamby, D. Rajagopal, and L.C. Eisenlohr. 2005. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6:287-294.
8. Zhou, D., P. Li, Y. Lin, J.M. Lott, A.D. Hislop, D.H. Canaday, R.R. Brutkiewicz, and J.S. Blum. 2005. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity. 22:571-581.
9. Jacobson, S., J.R. Richert, W.E. Biddison, A. Satinsky, R.J. Hartzman, and H.F. McFarland. 1984. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J. Immunol. 133:754-757.
10. Morrison, L.A., A.E. Lukacher, V.L. Braciale, D.P. Fan, and T.J. Braciale. 1986. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Exp. Med. 163:903-921.
11. Littaua, R.A., A. Takeda, J. Cruz, and F.A. Ennis. 1992. Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. J. Virol. 66:2274-2280.
12. Penna, A., P. Fowler, A. Bertoletti, S. Guilhot, B. Moss, R.F. Margolskee, A. Cavalli, A. Valli, F. Fiaccadori, F.V. Chisari, et al. 1992. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens. J. Virol. 66:1193-1198.
13. Green, S., I. Kurane, S. Pincus, E. Paoletti, and F.A. Ennis. 1997. Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones. Virology. 234:383-386.
14. Appay, V., J.J. Zaunders, L. Papagno, J. Sutton, A. Jaramillo, A. Waters, P. Easterbrook, P. Grey, D. Smith, A.J. McMichael, et al. 2002. Characterization of CD4(+) CTLs ex vivo. J. Immunol. 168:5954-5958.
15. Wahid, R., M.J. Cannon, and M. Chow. 2005. Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term t-cell memory in individuals vaccinated against polio. J. Virol. 79:5988-5995.
16. Arvin, A.M., M. Sharp, S. Smith, C.M. Koropchak, P.S. Diaz, P. Kinchington, W. Ruyechan, and J. Hay. 1991. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol. 146:257-264.
17. Gyulai, Z., V. Endresz, K. Burian, S. Pincus, J. Toldy, W.I. Cox, C. Meric, S. Plotkin, E. Gonczol, and K. Berencsi. 2000. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs. J. Infect. Dis. 181:1537-1546.
18. Munz, C., K.L. Bickham, M. Subklewe, M.L. Tsang, A. Chahroudi, M.G. Kurilla, D. Zhang, M. O'Donnell, and R.M. Steinman. 2000. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. Exp. Med. 191:1649-1660.
19. Schmid, D.S. 1988. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex. J. Immunol. 140:3610-3616.
20. Bourgault, I., A. Gomez, E. Gomard, F. Picard, and J.P. Levy. 1989. A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines. J. Immunol. 142:252-256.
21. Sun, Q., R.L. Burton, K.E. Pollok, D.J. Emanuel, and K.G. Lucas. 1999. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cell. Immunol. 195:81-88.
22. Jellison, E.R., S.K. Kim, and R.M. Welsh. 2005. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J. Immunol. 174:614-618.
23. Sylwester, A.W., B.L. Mitchell, J.B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P.R. Sleath, K.H. Grabstein, N.A. Hosken, F. Kern, et al. 2005. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202:673-685.
24. Riddell, S.R., K.S. Watanabe, J.M. Goodrich, C.R. Li, M.E. Agha, and P.D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:238-241.
25. Rentenaar, R.J., L.E. Gamadia, N. van DerHoek, F.N. van Diepen, R. Boom, J.F. Weel, P.M. Wertheim-van Dillen, R.A. van Lier, and I.J. ten Berge. 2000. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J. Clin. Invest. 105:541-548.
26. van Leeuwen, E.M., E.B. Remmerswaal, M.T. Vossen, A.T. Rowshani, P.M. Wertheim-van Dillen, R.A. van Lier, and I.J. ten Berge. 2004. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 173:1834-1841.
27. Gamadia, L.E., R.J. Rentenaar, R.A. van Lier, and I.J. ten Berge. 2004. Properties of CD4(+) T cells in human cytomegalovirus infection. Hum. Immunol. 65:486-492.
28. Sester, M., U. Sester, B. Gartner, G. Heine, M. Girndt, N. Mueller-Lantzsch, A. Meyerhans, and H. Kohler. 2001. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virusinduced disease after renal transplantation. Transplantation. 71:1287-1294.
29. Gamadia, L.E., E.B. Remmerswaal, J.F. Weel, F. Bemelman, R.A. van Lier, and I.J. Ten Berge. 2003. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood. 101:2686-2692.
30. Hopkins, J.I., A.N. Fiander, A.S. Evans, M. Delchambre, D. Gheysen, and L.K. Borysiewicz. 1996. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J. Med. Virol. 49:124-131.
31. Elkington, R., N.H. Shoukry, S. Walker, T. Crough, C. Fazou, A. Kaur, C.M. Walker, and R. Khanna. 2004. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Eur. J. Immunol. 34:3216-3226.
32. Jonjic, S., I. Pavic, P. Lucin, D. Rukavina, and U.H. Koszinowski. 1990. Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J. Virol. 64:5457-5464.
33. Hegde, N.R., M.S. Chevalier, and D.C. Johnson. 2003. Viral inhibition of MHC class II antigen presentation. Trends Immunol. 24:278-285.
34. Britt, W.J., and C.A. Alford. 1996. Cytomegalovirus. In Fields Virology. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman, and S.E. Strauss, editors. Lippincott-Raven, Philadelphia. 2493-2523.
35. Sanchez, V., K.D. Greis, E. Sztul, and W.J. Britt. 2000. Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J. Virol. 74:975-986.
36. Homman-Loudiyi, M., K. Hultenby, W. Britt, and C. Soderberg-Naucler. 2003. Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, transgolgi network 46, and mannosidase II. J. Virol. 77:3191-3203.
37. Tomazin, R., J. Boname, N.R. Hegde, D.M. Lewinsohn, Y. Altschuler, T.R. Jones, P. Cresswell, J.A. Nelson, S.R. Riddell, and D.C. Johnson. 1999. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med. 5:1039-1043.
38. Catalfamo, M., and P.A. Henkart. 2003. Perforin and the granule exocytosis cytotoxicity pathway. Curr. Opin. Immunol. 15:522-527.
39. Jarvis, M.A., K.N. Fish, C. Soderberg-Naucler, D.N. Streblow, H.L. Meyers, G. Thomas, and J.A. Nelson. 2002. Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells. J. Virol. 76:5147-5155.
40. Hegde, N.R., and D.C. Johnson. 2003. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells. J. Virol. 77:9287-9294.
41. Borza, C.M., and L.M. Hutt-Fletcher. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8:594-599.
42. Carlson, C., W.J. Britt, and T. Compton. 1997. Expression, purification, and characterization of a soluble form of human cytomegalovirus glycoprotein B. Virology. 239:198-205.
43. Saxena, U., M.G. Klein, and I.J. Goldberg. 1990. Metabolism of endothelial cell-bound lipoprotein lipase. Evidence for heparan sulfate proteoglycan-mediated internalization and recycling. J. Biol. Chem. 265:12880-12886.
44. Dillon, D.C., M.R. Alderson, C.H. Day, D.M. Lewinsohn, R. Coler, T. Bement, A. Campos-Neto, Y.A. Skeiky, I.M. Orme, A. Roberts, et al. 1999. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect. Immun. 67:2941-2950.
45. Hegde, N.R., R.A. Tomazin, T.W. Wisner, C. Dunn, J.M. Boname, D.M. Lewinsohn, and D.C. Johnson. 2002. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 76:10929-10941.
46. Lewinsohn, D.A., R.A. Lines, and D.M. Lewinsohn. 2002. Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis-specific CD8+ T cells. Am. J. Respir. Crit. Care Med. 166:843-848.
47. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:411-415.
48. Jarvis, M.A., T.R. Jones, D.D. Drummond, P.P. Smith, W.J. Britt, J.A. Nelson, and C.J. Baldick. 2004. Phosphorylation of human cytomegalovirus glycoprotein B (gB) at the acidic cluster casein kinase 2 site (Ser900) is required for localization of gB to the trans-Golgi network and efficient virus replication. J. Virol. 78:285-293.
49. Browne, H., S. Bell, T. Minson, and D.W. Wilson. 1996. An endoplasmic reticulum-retained herpes simplex virus glycoprotein H is absent from secreted virions: evidence for reenvelopment during egress. J. Virol. 70:4311-4316.
50. Murphy, E., D. Yu, J. Grimwood, J. Schmutz, M. Dickson, M.A. Jarvis, G. Hahn, J.A. Nelson, R.M. Myers, and T.E. Shenk. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA. 100:14976-14981.
51. Jaraquemada, D., M. Marti, and E.O. Long. 1990. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp. Med. 172:947-954.
52. Malnati, M.S., S. Ceman, M. Weston, R. DeMars, and E.O. Long. 1993. Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC. J. Immunol. 151:6751-6756.
53. Walter, E.A., P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, E.D. Thomas, and S.R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
54. Lord, S.J., R.V. Rajotte, G.S. Korbutt, and R.C. Bleackley. 2003. Granzyme B: a natural born killer. Immunol. Rev. 193:31-38.
55. Griffin, J.P., R. Chu, and C.V. Harding. 1997. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J. Immunol. 158:1523-1532.
56. Bonifaz, L.C., S. Arzate, and J. Moreno. 1999. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments. Eur. J. Immunol. 29:119-131.
57. Johnson, D.C., and G. McFadden. 2002. Viral immune evasion. In Immunology of Infectious Diseases. S.H.E. Kaufmann, A. Sher, and R. Ahmed, editors. American Society for Microbiology, Washington, D.C. 357-377.
58. Yewdell, J.W., and A.B. Hill. 2002. Viral interference with antigen presentation. Nat. Immunol. 3:1019-1025.
59. Hengel, H., U. Reusch, G. Geginat, R. Holtappels, T. Ruppert, E. Hellebrand, and U.H. Koszinowski. 2000. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J. Virol. 74:7861-7868.
60. Manley, T.J., L. Luy, T. Jones, M. Boeckh, H. Mutimer, and S.R. Riddell. 2004. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic t cell response in natural infection. Blood. 104:1075-1082.
61. Prudhomme, J.G., I.W. Sherman, K.M. Land, A.V. Moses, S. Stenglein, and J.A. Nelson. 1996. Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. Int. J. Parasitol. 26:647-655.
62. Moses, A.V., K.N. Fish, R. Ruhl, P.P. Smith, J.G. Strussenberg, L. Zhu, B. Chandran, and J.A. Nelson. 1999. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 73:6892-6902.
63. Riddell, S.R., and P.D. Greenberg. 1990. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods. 128:189-201.
64. Collins, W.J., and D.C. Johnson. 2003. Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread. J. Virol. 77:2686-2695.
65. Chapman, T.L., I. You, I.M. Joseph, P.J. Bjorkman, S.L. Morrison, and M. Raghavan. 1999. Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. J. Biol. Chem. 274:6911-6919.
66. Britt, W.J. 1984. Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology. 135:369-378.
67. Salerno-Goncalves, R., M. Fernandez-Vina, D.M. Lewinsohn, and M.B. Sztein. 2004. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 173:5852-5862.
68. York, I.A., C. Roop, D.W. Andrews, S.R. Riddell, F.L. Graham, and D.C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell. 77:525-535.